Preventing ischemic heart disease in women: a systematic review of global directives and policies
Mensah, G. A., Roth, G. A. & Fuster, V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J. Am. Coll. Cardiol. 74, 2529–2532 (2019).
Google Scholar
Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982–3021 (2020).
Google Scholar
Vaughan, A. S., Schieb, L. & Casper, M. Historic and recent trends in county-level coronary heart disease death rates by race, gender, and age group, United States, 1979-2017. PLoS One 15, e0235839 (2020).
Google Scholar
Vlassoff, C. Gender differences in determinants and consequences of health and illness. J. Health Popul. Nutr. 25, 47–61 (2007).
Google Scholar
Nussbaum, S. S. et al. Sex-specific considerations in the presentation, diagnosis, and management of ischemic heart disease. J. Am. Coll. Cardiol. 79, 1398–1406 (2022).
Google Scholar
Garcia, M., Mulvagh, S. L., Bairey Merz, C. N., Buring, J. E. & Manson, J. E. Cardiovascular disease in women: Clinical perspectives. Circ. Res. 118, 1273–1293 (2016).
Google Scholar
Mosca, L., Barrett-Connor, E. & Wenger, N. K. Sex/gender differences in cardiovascular disease prevention. Circulation 124, 2145–2154 (2011).
Google Scholar
Wenger, N. K. Coronary heart disease: the female heart is vulnerable. Prog. Cardiovasc. Dis. 46, 199–229 (2003).
Google Scholar
Geraghty, L. et al. Cardiovascular disease in women: From pathophysiology to novel and emerging risk factors. Heart Lung Circ. 30, 9–17 (2021).
Google Scholar
Majidi, M., Eslami, V., Ghorbani, P. & Foroughi, M. Are women more susceptible to ischemic heart disease compared to men? A literature overview. J. Geriatr. Cardiol. 18, 289–296 (2021).
Google Scholar
Yerman, T., Gan, W. Q. & Sin, D. D. The influence of gender on the effects of aspirin in preventing myocardial infarction. BMC Med 5, 29 (2007).
Google Scholar
Tamargo, J. et al. Gender differences in the effects of cardiovascular drugs. Eur. Heart J. – Cardiovascular Pharmacother. 3, 163–182 (2017).
Google Scholar
Raine, R. Does gender bias exist in the use of specialist health care? J. Health Serv. Res. Policy 5, 237–249 (2000).
Google Scholar
Perju-Mitran, A. & Budacia, A. E. Gender differences in modeling the influence of online marketing communication on behavioral intentions. Procedia Econ. Financ. 27, 567–573 (2015).
Google Scholar
Parvazian, S., Gill, J. & Chiera, B. Higher education, women, and sociocultural change: A closer look at the statistics. SAGE Open 7, 2158244017700230 (2017).
Google Scholar
Pelletier, R. et al. Sex versus gender-related characteristics: Which predicts outcome after acute coronary syndrome in the young? J. Am. Coll. Cardiol. 67, 127–135 (2016).
Google Scholar
Schiebinger, L. & Stefanick, M. L. Gender matters in biological research and medical practice∗. J. Am. Coll. Cardiol. 67, 136–138 (2016).
Google Scholar
Davidson, P. M. et al. Improving women’s cardiovascular health: A position statement from the international council on women’s health issues. Health Care Women Int 33, 943–955 (2012).
Google Scholar
Khan, S. U. et al. A comparative analysis of premature heart disease- and cancer-related mortality in women in the USA, 1999–2018. Eur. Heart J. – Qual. Care Clin. Outcomes 8, 315–323 (2021).
Google Scholar
Meyer, M. R. et al. Gender differences in patient and system delay for primary percutaneous coronary intervention: current trends in a Swiss ST-segment elevation myocardial infarction population. Eur. Heart J. Acute Cardiovascular Care 8, 283–290 (2019).
Google Scholar
Bairey Merz, C. N. et al. Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: The women’s heart alliance. J. Am. Coll. Cardiol. 70, 123–132 (2017).
Google Scholar
Wharton-Smith, A. et al. Gender-related factors affecting health seeking for neglected tropical diseases: findings from a qualitative study in Ethiopia. PLoS Negl. Trop. Dis. 13, e0007840 (2019).
Google Scholar
Surya, B. et al. A cross-sectional study on health-seeking behavior in relation to reproductive tract infection among ever-married rural women in Kancheepuram district, Tamil Nadu. J. Fam. Med Prim. Care 10, 3424–3428 (2021).
Google Scholar
Clerc Liaudat, C. et al. Sex/gender bias in the management of chest pain in ambulatory care. Women’s Health (Lond.) 14, 1745506518805641 (2018).
Google Scholar
Gulati, M., Hendry, C., Parapid, B. & Mulvagh, S. L. Why we need specialised centres for women’s hearts: Changing the face of cardiovascular care for women. Eur. Cardiol. 16, e52 (2021).
Google Scholar
Ezekowitz, J. A. et al. Is there a sex gap in surviving an acute coronary syndrome or subsequent development of heart failure? Circulation 142, 2231–2239 (2020).
Google Scholar
Bots, S. H., Peters, S. A. E. & Woodward, M. Sex differences in coronary heart disease and stroke mortality: A global assessment of the effect of ageing between 1980 and 2010. BMJ Glob. Health 2, e000298 (2017).
Google Scholar
Benjamin, E. J. et al. Heart disease and stroke statistics-2019 update: A report from the american heart association. Circulation 139, e56–e528 (2019).
Google Scholar
Women, U. The Beijing Declaration and Platform for Action Turns 20, Summary Report. (UN Women New York, 2015).
Britnell, M. The role of the ‘specialist’ in healthcare. Clin. Med. (Lond.) 11, 329–331 (2011).
Google Scholar
Hazel, K. L. & Kleyman, K. S. Gender and sex inequalities: Implications and resistance. J. Prev. Inter. Community 48, 281–292 (2020).
Google Scholar
Rodriguez, F. & Foody, J. M. is cardiovascular disease in young women overlooked? Women’s Health 9, 213–215 (2013).
Google Scholar
Mehta, P. K., Wei, J. & Wenger, N. K. Ischemic heart disease in women: A focus on risk factors. Trends Cardiovasc. Med. 25, 140–151 (2015).
Google Scholar
Remsberg, K. E. et al. Early menarche and the development of cardiovascular disease risk factors in adolescent girls: The Fels Longitudinal Study. J. Clin. Endocrinol. Metab. 90, 2718–2724 (2005).
Google Scholar
Jacobsen, B. K., Oda, K., Knutsen, S. F. & Fraser, G. E. Age at menarche, total mortality and mortality from ischaemic heart disease and stroke: the Adventist Health Study, 1976-88. Int. J. Epidemiol. 38, 245–252 (2009).
Google Scholar
Bajuk Studen, K. & Pfeifer, M. Cardiometabolic risk in polycystic ovary syndrome. Endocr. Connect 7, R238–r251 (2018).
Google Scholar
ESHRE Capri Workshop Group. Hormones and cardiovascular health in women. Hum. Reprod. Update 12, 483-497 (2006).
Di Cianni, G., Ghio, A., Resi, V. & Volpe, L. Gestational diabetes mellitus: An opportunity to prevent type 2 diabetes and cardiovascular disease in young women. Women’s Health 6, 97–105 (2010).
Google Scholar
Osibogun, O., Ogunmoroti, O. & Michos, E. D. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention. Trends Cardiovasc. Med. 30, 399–404 (2020).
Google Scholar
Guan, C. et al. Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease. Fertil. Steril. 117, 924–935 (2022).
Google Scholar
Dokras, A. Heart health in polycystic ovary syndrome: time to act on the data. Fertil. Steril. 117, 885–886 (2022).
Google Scholar
Balla, S., Ekpo, E. P., Wilemon, K. A., Knowles, J. W. & Rodriguez, F. Women living with familial hypercholesterolemia: challenges and considerations surrounding their care. Curr. Atherosclerosis Rep. 22, 1–13 (2020).
Google Scholar
Rajadurai, J. et al. Women’s cardiovascular health: Perspectives from South-East Asia. Nat. Rev. Cardiol. 9, 464–477 (2012).
Google Scholar
Mackay, J. & Amos, A. Women and tobacco. Respirology 8, 123–130 (2003).
Google Scholar
Moodie, C. et al. Plain tobacco packaging: Progress, challenges, learning and opportunities. Tob. Control 31, 263–271 (2022).
Google Scholar
Tarran, R. et al. E-cigarettes and cardiopulmonary health. Function 2, zqab004 (2021).
Google Scholar
Farsalinos, K. E., Polosa, R., Cibella, F. & Niaura, R. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Ther. Adv. Chronic Dis. 10, 2040622319877741 (2019).
Google Scholar
Osei, A. D. et al. Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers. Am. J. Med. 132, 949–954. e942 (2019).
Google Scholar
Alzahrani, T., Pena, I., Temesgen, N. & Glantz, S. A. Association between electronic cigarette use and myocardial infarction. Am. J. Prevent. Med. 55, 455–461 (2018).
Google Scholar
Hutcheon, J. A., Lisonkova, S. & Joseph, K. S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 25, 391–403 (2011).
Google Scholar
Gelson, E., Gatzoulis, M., Steer, P. & Johnson, M. Heart disease – why is maternal mortality increasing? BJOG 116, 609–611 (2009).
Google Scholar
Rich-Edwards, J. W., Fraser, A., Lawlor, D. A. & Catov, J. M. Pregnancy characteristics and women’s future cardiovascular health: An underused opportunity to improve women’s health? Epidemiol. Rev. 36, 57–70 (2013).
Google Scholar
Arabin, B. & Baschat, A. A. Pregnancy: An underutilized window of opportunity to improve long-term maternal and infant health-an appeal for continuous family care and interdisciplinary communication. Front Pediatr. 5, 69 (2017).
Google Scholar
Parikh, N. I. et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: A scientific statement from the American Heart Association. Circulation 143, e902–e916 (2021).
Google Scholar
Hauspurg, A., Ying, W., Hubel, C. A., Michos, E. D. & Ouyang, P. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin. Cardiol. 41, 239–246 (2018).
Google Scholar
Quesada, O., Shufelt, C. & Bairey Merz, C. N. Can we improve cardiovascular disease for women using data under our noses?: A need for changes in policy and focus. JAMA Cardiol. 5, 1398–1400 (2020).
Google Scholar
Park, K., Minissian, M. B., Wei, J., Saade, G. R. & Smith, G. N. Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes. Clin. Cardiol. 43, 553–559 (2020).
Google Scholar
Nelson, S. M. & Greer, I. A. Hypertensive disorders of pregnancy: Preventative-, immediate- and long-term management. Expert Rev. Pharmacoecon. Outcomes Res. 6, 541–554 (2006).
Google Scholar
Seely, E. W., Tsigas, E. & Rich-Edwards, J. W. Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients? Semin. Perinatol. 39, 276–283 (2015).
Google Scholar
Sandsæter, H. L., Horn, J., Rich-Edwards, J. W. & Haugdahl, H. S. Preeclampsia, gestational diabetes and later risk of cardiovascular disease: Women’s experiences and motivation for lifestyle changes explored in focus group interviews. BMC Pregnancy Childbirth 19, 448 (2019).
Google Scholar
Hird, M. J., Yoshizawa, R. S., Robinson, S., Smith, G. & Walker, M. Risk for cardiovascular disease after pre-eclampsia: Differences in Canadian women and healthcare provider perspectives on knowledge sharing. Health Sociol. Rev. 26, 128–142 (2017).
Google Scholar
Bernstein, J. A. et al. Follow-up after gestational diabetes: a fixable gap in women’s preventive healthcare. BMJ Open Diab. Res. Care 5, e000445 (2017).
Google Scholar
Bond, R. M. et al. Cardiovascular health of black women before, during, and after pregnancy: A call to action and implications for prevention. Curr. Cardiovascular Risk Rep. 16, 171–180 (2022).
Google Scholar
Khosla, K. et al. Long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: Recent advances in hypertension. Hypertension 78, 927–935 (2021).
Google Scholar
Mussa, J., Rahme, E., Dahhou, M., Nakhla, M. & Dasgupta, K. Considering gestational diabetes and gestational hypertension history across two pregnancies in relationship to cardiovascular disease development: A retrospective cohort study. Diab. Res. Clin. Pract. 206, 110998 (2023).
Google Scholar
Mosca, L. et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J. Am. Coll. Cardiol. 57, 1404–1423 (2011).
Google Scholar
O’Kelly, A. C., Ludmir, J. & Wood, M. J. Acute coronary syndrome in pregnancy and the post-partum period. J. Cardiovascular Dev. Dis. 9, 198 (2022).
Google Scholar
Regitz-Zagrosek, V. et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur. Heart J. 39, 3165–3241 (2018).
Google Scholar
Martins, L. C., Freire, C. M., Capuruçu, C. A., Nunes, M. D. C. & Rezende, C. A. Risk prediction of cardiovascular complications in pregnant women with heart disease. Arq. Bras. Cardiol. 106, 289–296 (2016).
Google Scholar
Balci, A. et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart 100, 1373–1381 (2014).
Google Scholar
Kotit, S. & Yacoub, M. Cardiovascular adverse events in pregnancy: A global perspective. Glob. Cardiol. Sci. Pr. 2021, e202105 (2021).
Anderson, A. S. Dietary interventions in low-income women – issues for UK policy. Nutr. Bull. 32, 15–20 (2007).
Google Scholar
Plotnikoff, R. C., Hugo, K., Wielgosz, A., Wilson, E. & MacQuarrie, D. Heart disease and stroke in Canadian women: policy development. Can. J. Public Health 91, 58–59 (2000).
Google Scholar
Institute, U. O. O. H. Canadian Women’s Heart Health Centre. Women@Heart Program, https://cwhhc.ottawaheart.ca/programs-and-services/programs-and-services.
Thomas, A. J., Mitchell, E. S. & Woods, N. F. The challenges of midlife women: themes from the Seattle midlife women’s health study. Women’s. Midlife Health 4, 1–10 (2018).
Google Scholar
El Khoudary, S. R. et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 142, e506–e532 (2020).
Google Scholar
Vitale, C., Miceli, M. & Rosano, G. M. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 10, 16–20 (2007).
Google Scholar
Wathen, C. N., Feig, D. S., Feightner, J. W., Abramson, B. L. & Cheung, A. M. Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 170, 1535–1537 (2004).
Google Scholar
Kim, H. R. & Yang, H. M. Facilitators and inhibitors of lifestyle modification and maintenance of KOREAN postmenopausal women: Revealing conversations from FOCUS group interview. Int. J. Environ. Res. Public Health 17. (2020).
Collins, P. et al. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric 10, 508–526 (2007).
Google Scholar
Rosano, G. M., Vitale, C. & Tulli, A. Managing cardiovascular risk in menopausal women. Climacteric 9, 19–27 (2006).
Google Scholar
Mikkola, T. S., Savolainen-Peltonen, H., Venetkoski, M. & Ylikorkala, O. New evidence for cardiac benefit of postmenopausal hormone therapy. Climacteric 20, 5–10 (2017).
Google Scholar
Prabakaran, S., Schwartz, A. & Lundberg, G. Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use. Ther. Adv. Endocrinol. Metab. 12, 20420188211013917 (2021).
Google Scholar
Hsu, C. H. et al. High normotension is associated with higher metabolic syndrome risk in postmenopausal women. Geriatr. Gerontol. Int 14, 293–300 (2014).
Google Scholar
Wenger, N. K. HT and CVD prevention. from myth to reality. Fertil. Steril. 80, 10–14 (2003). quiz 54-15.
Google Scholar
Christ, J. P. et al. Estrogen deprivation and cardiovascular disease risk in primary ovarian insufficiency. Fertil. Steril. 109, 594–600.e591 (2018).
Google Scholar
Karvonen-Gutierrez, C. & Kim, C. Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition. Healthcare 4, 42 (2016).
Google Scholar
Kozakowski, J., Gietka-Czernel, M., Leszczyńska, D. & Majos, A. Obesity in menopause – our negligence or an unfortunate inevitability? Prz. Menopauzalny 16, 61–65 (2017).
Google Scholar
Dikaiou, P. et al. Obesity, overweight and risk for cardiovascular disease and mortality in young women. Eur. J. Prev. Cardiol. 28, 1351–1359 (2021).
Google Scholar
Taylor, L. E., Ramirez, L. A., Musall, J. B. & Sullivan, J. C. Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction? Br. J. Pharm. 176, 4226–4242 (2019).
Google Scholar
Sawatzky, J.-A. & Naimark, B. Physical activity and cardiovascular health in aging women: A health-promotion perspective. J. Aging Phys. Act. 10, 396–412 (2002).
Google Scholar
Virani, S. S. et al. Heart disease and stroke statistics-2021 update: A Report From the American Heart Association. Circulation 143, e254–e743 (2021).
Google Scholar
Schwarz, S. & Dören, M. Important risk factors of common diseases in women at midlife and beyond. J. Public Health 15, 81–85 (2007).
Google Scholar
Hodis, H. N. & Mack, W. J. Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: It is about time and timing. Cancer J. 28, 208–223 (2022).
Google Scholar
Pines, A. et al. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 10, 181–194 (2007).
Google Scholar
Will, J. C. & Loo, R. K. The WISEWOMAN program: Reflection and forecast. Prev. Chronic Dis. 5, A56 (2008).
Google Scholar
Yancey, A. K. Building capacity to prevent and control chronic disease in underserved communities: Expanding the wisdom of WISEWOMAN in intervening at the environmental level. J. Women’s Health (Larchmt.) 13, 644–649 (2004).
Google Scholar
Will, J. C., Farris, R. P., Sanders, C. G., Stockmyer, C. K. & Finkelstein, E. A. Health promotion interventions for disadvantaged women: overview of the WISEWOMAN projects. J. Women’s Health (Larchmt) 13, 484–502 (2004).
Google Scholar
Besculides, M. et al. Best practices in implementing lifestyle interventions in the WISEWOMAN program: Adaptable strategies for public health programs. Am. J. Health Promot. 22, 322–328 (2008).
Google Scholar
Tabue-Teguo, M. et al. Frailty in elderly: a brief review. Geriatr. Psychol. Neuropsychiatr. Vieil. 15, 127–137 (2017).
Google Scholar
Institute of Medicine Committee on Quality of Health Care in, A. in Crossing the Quality Chasm: A New Health System for the 21st Century (National Academies Press (US) Copyright 2001 by the National Academy of Sciences. All rights reserved., 2001).
Golaszewski, N. M. et al. Evaluation of social isolation, loneliness, and cardiovascular disease among older women in the US. JAMA Netw. Open 5, e2146461 (2022).
Google Scholar
Mankad, R. & Best, P. J. Cardiovascular disease in older women: a challenge in diagnosis and treatment. Women’s Health (Lond.) 4, 449–464 (2008).
Google Scholar
Tabloski, P. A. Global aging: implications for women and women’s health. J. Obstet. Gynecol. Neonatal Nurs. 33, 627–638 (2004).
Google Scholar
Kalibala, J., Pechère-Bertschi, A. & Desmeules, J. Gender differences in cardiovascular pharmacotherapy-the example of hypertension: A mini review. Front. Pharmacol. 11, 564 (2020).
Google Scholar
Johnson, P. A. Racial and ethnic disparities in coronary heart disease in women: Prevention, treatment, and needed interventions. ACC Curr. J. Rev. 13, 22–25 (2004).
Google Scholar
Giardina, E. G. et al. Relationship between cardiovascular disease knowledge and race/ethnicity, education, and weight status. Clin. Cardiol. 35, 43–48 (2012).
Google Scholar
Beckie, T. M. Ethnic and racial disparities in hypertension management among women. Semin. Perinatol. 41, 278–286 (2017).
Google Scholar
Cong, L. et al. Overweight and obesity among low-income Muslim Uyghur women in far western China: correlations of body mass index with blood lipids and implications in preventive public health. PLoS One 9, e90262 (2014).
Google Scholar
Pearson, T. L. Cardiovascular risk in minority and underserved women in Appalachian Tennessee: A descriptive study. J. Am. Acad. Nurse Pract. 22, 210–216 (2010).
Google Scholar
Foody, J. M. et al. The office on women’s health initiative to improve women’s heart health: Program description, site characteristics, and lessons learned. J. Women’s Health 19, 507–516 (2010).
Google Scholar
Nicasio, J., El-Atat, F., McFarlane, S. I. & LaRosa, J. H. Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women. Curr. Diab Rep. 5, 208–213 (2005).
Google Scholar
Young, L. E., Cunningham, S. L. & Buist, D. S. Lone mothers are at higher risk for cardiovascular disease compared with partnered mothers. Data from the National Health and Nutrition Examination Survey III (NHANES III). Health Care Women Int. 26, 604–621 (2005).
Google Scholar
Evans, L. K. Because we don’t take better care of ourselves: rural Black women’s explanatory models of heart disease. J. Women Aging 22, 94–108 (2010).
Google Scholar
Zimmermann, K. et al. Southern Seven Womenapos;s Initiative for Cardiovascular Health. Am. J. Health Educ. 43, 349–355 (2012).
Google Scholar
Ziabakhsh, S., Pederson, A., Prodan-Bhalla, N., Middagh, D. & Jinkerson-Brass, S. Women-centered and culturally responsive heart health promotion among indigenous women in Canada. Health Promotion Pract. 17, 814–826 (2016).
Google Scholar
Fahs, P. S. et al. Promoting heart health in rural women. J. Rural Health 29, 248–257 (2013).
Google Scholar
Koniak-Griffin, D. & Brecht, M.-L. Awareness of cardiovascular disease and preventive behaviors among overweight immigrant latinas. J. Cardiovasc. Nurs. 30, 447–455 (2015).
Google Scholar
Stoddard, A. M., Palombo, R., Troped, P. J., Sorensen, G. & Will, J. C. Cardiovascular disease risk reduction: The Massachusetts WISEWOMAN project. J. Women’s Health 13, 539–546 (2004).
Google Scholar
Alreshidi, B. G., Kalman, M., Wells, M. & Fahs, P. S. Cardiovascular Risk Reduction in Rural Women: A Literature Synthesis. J. Cardiovasc. Nurs. 35, 199–209 (2020).
Google Scholar
Peix, A. & Paez, D. Ischemic heart disease in Latin American women current perspective and call to action. J. Nucl. Cardiol. 26, 1361–1364 (2019).
Google Scholar
Choi, E. J. et al. Middle-aged women’s awareness of cholesterol as a risk factor: Results from a national survey of Korean Middle-aged Women’s Health Awareness (KomWHA) study. Int. J. Nurs. Stud. 47, 452–460 (2010).
Google Scholar
Cheng, D. Preventing cardiovascular disease among low-income women of reproductive age. J. Women’s Health (Larchmt.) 22, 312–313 (2013).
Google Scholar
Zarate-Abbott, P. et al. Workplace health promotion-strategies for low-income Hispanic immigrant women. AAOHN J. 56, 217–222 (2008).
Google Scholar
Kandasamy, S. & Anand, S. S. Cardiovascular disease among women from vulnerable populations: A review. Can. J. Cardiol. 34, 450–457 (2018).
Google Scholar
Rashid, N. A., Nawi, A. M. & Khadijah, S. Exploratory analysis of traditional risk factors of ischemic heart disease (IHD) among predominantly Malay Malaysian women. BMC Public Health 19, 545 (2019).
Google Scholar
Young, L. E., James, A. D. & Cunningham, S. L. Lone motherhood and risk for cardiovascular disease: the National Population Health Survey (NPHS), 1998-99. Can. J. Public Health 95, 329–335 (2004).
Google Scholar
Kentoffio, K., Temu, T. M., Shakil, S. S., Zanni, M. V. & Longenecker, C. T. Cardiovascular disease risk in women living with HIV. Curr. Opin. HIV AIDS 17, 270–278 (2022).
Google Scholar
Leiter, E. et al. Cardiovascular disease risk factors and health behaviors of ultra-orthodox Jewish women in Israel: a comparison study. Ethnicity Health 27, 1031–1046 (2022).
Google Scholar
Schultz, W. M. et al. Socioeconomic status and cardiovascular outcomes. Circulation 137, 2166–2178 (2018).
Google Scholar
Zambahari, R. et al. Clinical practice guidelines. Prevention of cardiovascular disease in women. (2016).
Chiang, C. E. et al. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. J. Chin. Med. Assoc. 78, 1–47 (2015).
Google Scholar
Williams, B. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur. Heart J. 39, 3021–3104 (2018).
Google Scholar
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71, 1269–1324 (2018).
Google Scholar
Association, A. D. 8. Cardiovascular disease and risk management. Diab. Care 38, S49–S57 (2014).
Google Scholar
Gerdts, E. et al. Sex differences in arterial hypertension: a scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy. Eur. heart J. 43, 4777–4788 (2022).
Google Scholar
Politi, C. et al. Gender medicine: An up-date. Italian J. Med 7, 96–106 (2013).
Google Scholar
Loomba, R. S. & Arora, R. Prevention of coronary heart disease in women. Ther. Adv. Cardiovasc. Dis. 2, 321–327 (2008).
Google Scholar
Berger, J. S. et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 295, 306–313 (2006).
Google Scholar
Mitka, M. A change of heart guidelines for women. JAMA 297, 1421–1422 (2007).
Google Scholar
Raeisi-Giglou, P. et al. Advances in Cardiovascular Health in Women over the Past Decade: Guideline Recommendations for Practice. J. Women’s Health (Larchmt.) 27, 128–139 (2018).
Google Scholar
Mercuro, G., Deidda, M., Bina, A., Manconi, E. & Rosano, G. M. Gender-specific aspects in primary and secondary prevention of cardiovascular disease. Curr. Pharm. Des. 17, 1082–1089 (2011).
Google Scholar
Daubert, M. A. & Douglas, P. S. Primary prevention of heart failure in women. JACC Heart Fail 7, 181–191 (2019).
Google Scholar
Wenger, N. K. What Do the 2011 American Heart Association guidelines tell us about prevention of cardiovascular disease in women? Clin. Cardiol. 34, 520–523 (2011).
Google Scholar
Engberding, N. & Wenger, N. K. Cardiovascular disease prevention tailored for women. Expert Rev. Cardiovasc. Ther. 6, 1123–1134 (2008).
Google Scholar
Wenger, N. K. Coronary heart disease in women: highlights of the past 2 years—stepping stones, milestones and obstructing boulders. Nat. Clin. Pract. Cardiovascular Med. 3, 194–202 (2006).
Google Scholar
Bhakta, M. D., Mookadam, F. & Wilansky, S. Cardiovascular disease in women. Future Cardiol. 7, 613–627 (2011).
Google Scholar
Engberding, N. & Wenger, N. K. Management of hypertension in women. Hypertens. Res. 35, 251–260 (2012).
Google Scholar
Azad, N. & Nishtar, S. A call for a gender specific approach to address the worldwide cardiovascular burden. Prev. Control 1, 223–227 (2005).
Vogel, B. et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 397, 2385–2438 (2021).
Google Scholar
Pascale, A., Beal, M. W. & Fitzgerald, T. Rethinking the well woman visit: A scoping review to identify eight priority areas for well woman care in the era of the affordable care act. Women’s Health Issues 26, 135–146 (2016).
Google Scholar
Whitlock, E. P. & Williams, S. B. The primary prevention of heart disease in women through health behavior change promotion in primary care. Women’s Health Issues 13, 122–141 (2003).
Google Scholar
Cabana, M. D. & Kim, C. Physician adherence to preventive cardiology guidelines for women. Women’s Health Issues 13, 142–149 (2003).
Google Scholar
Hayes, S. N., Wood, S. F., Mieres, J. H., Campbell, S. M. & Wenger, N. K. Taking a giant step toward women’s heart health: Finding policy solutions to unanswered research questions. Women’s Health Issues 25, 429–432 (2015).
Google Scholar
Stramba-Badiale, M. et al. Cardiovascular diseases in women: A statement from the policy conference of the European Society of Cardiology. Eur. Heart J. 27, 994–1005 (2006).
Google Scholar
Krummel, D. A. et al. Cardiovascular health interventions in women: What works? J. Women’s Health Gend. Based Med. 10, 117–136 (2001).
Google Scholar
Kouvari, M., Souliotis, K., Yannakoulia, M. & Panagiotakos, D. B. Cardiovascular diseases in women: Policies and practices around the globe to achieve gender equity in cardiac health. Risk Manag. Healthc. Policy 13, 2079–2094 (2020).
Google Scholar
Wenger, N. K. Gender disparity in cardiovascular disease: Bias or biology? Expert Rev. Cardiovasc. Ther. 10, 1401–1411 (2012).
Google Scholar
Hayes, S. N., Weisman, C. S. & Clark, A. The Jacobs Institute of Women’s Health report on the prevention of heart disease in women: findings and recommendations from the “Women and Heart Disease: Putting Prevention into Primary Care” conference. Women’s Health Issues 13, 115–121 (2003).
Google Scholar
Mitchell, J. A. Champions for change: The Heart Foundation’s Quest to Address Heart Disease in Australian Women. Heart, Lung Circulation 30, 6–8 (2021).
Google Scholar
Comer, S. K, Dutta, M. J. Women’s Heart Health in Singapore: A Culture-Centered Framework. CARE white paper series 1 (2013).
Prince, S. et al. Charting the course for women’s heart health in canada: recommendations from the first canadian women’s heart health summit. Can. J. Cardiol. 33, 693–700 (2017).
Google Scholar
Jones, D. W. et al. Partnering to reduce risks and improve cardiovascular outcomes. Circulation 119, 340–350 (2009).
Google Scholar
Go Red for Women, (2022).
Ms. Understood – Heart & Stroke 2018 Heart Report. (Heart & Stroke Foundation of Canada).
Clark, M. I. et al. Taking a hard look at the Heart Truth campaign in Canada: A discourse analysis. J. health Psychol. 23, 1699–1710 (2018).
Google Scholar
Gooding, H. C. et al. Will teens go red? low cardiovascular disease awareness among young women. J. Am. Heart Assoc. 8, e011195 (2019).
Google Scholar
Wang, L. Y. T. et al. Health information needs and dissemination methods for individuals living with ischemic heart disease: A systematic review. Patient Educ. Couns. 108, 107594 (2023).
Google Scholar
World Health Report. Reducing risks, promoting healthy life. (World Health Organization, 2002).
James, C. D. et al. To retain or remove user fees? Reflections on the current debate in low-and middle-income countries. Appl. health Econ. health policy 5, 137–153 (2006).
Google Scholar
Etemadi, M. & Hajizadeh, M. User fee removal for the poor: a qualitative study to explore policies for social health assistance in Iran. BMC Health Serv. Res. 22, 1–12 (2022).
Google Scholar
Budde, H., Williams, G. A., Scarpetti, G., Kroezen, M. & Maier, C. B. What are patient navigators and how can they improve integration of care?, (European Observatory on Health Systems and Policies, 2022).
Budde, H., Williams, G. A., Winkelmann, J., Pfirter, L. & Maier, C. B. The role of patient navigators in ambulatory care: overview of systematic reviews. BMC Health Serv. Res. 21, 1–12 (2021).
Google Scholar
Gholizadeh, L. & Davidson, P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int 29, 3–22 (2008).
Google Scholar
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).
Google Scholar
Michael Howlett, M. R., Anthony Perl Studying Public Policy: Policy Cycles and Policy Subsystems. 3rd edn, (Oxford University Press, 2009).
CDC. Centers for Disease Control and Prevention – Definition of Policy. 2023.
Joanna Briggs Institute Critical appraisal tools. 2023.
Aromataris, E. et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J. Evid. Based Health. 13, 132–140 (2015).
Google Scholar
Barker, T. H. et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI Evid. Synth. 21, 494–506 (2023).
Google Scholar
McArthur, A., Klugárová, J., Yan, H. & Florescu, S. Innovations in the systematic review of text and opinion. Int J. Evid. Based Health. 13, 188–195 (2015).
Google Scholar
Lockwood, C., Munn, Z. & Porritt, K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J. Evid. Based Health. 13, 179–187 (2015).
Google Scholar
Bown, M. J. & Sutton, A. J. Quality control in systematic reviews and meta-analyses. Eur. J. Vasc. Endovasc. Surg. 40, 669–677 (2010).
Google Scholar
Ben-Shlomo, Y. & Kuh, D. A life course approach to chronic disease epidemiology: Conceptual models, empirical challenges and interdisciplinary perspectives. Int. J. Epidemiol. 31, 285–293 (2002).
Google Scholar
Litvak, E. et al. Making sense of what exactly public health does: a typology of public health interventions. Can. J. Public Health 111, 65–71 (2020).
Google Scholar
Volpe, M. et al. Cardiovascular disease in women with HIV-1 infection. Int. J. Cardiol. 241, 50–56 (2017).
Google Scholar
Adedinsewo, D. A. et al. Cardiovascular disease screening in women: leveraging artificial intelligence and digital tools. Circulation Res. 130, 673–690 (2022).
Google Scholar
link
:quality(85):upscale()/2024/12/04/799/n/1922153/b75c544667509b4fd65d97.33975776_.jpg "Harms of Unsolicited Skin-Care Advice")
